Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT02270034Phase 1Completed
Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma
Glioblastoma Multiforme (Grade IV) of Cerebellum
StudychairStart date: 2014-08-13
NCT01577784Phase 2Unknown
Pazopanib in Second-line Therapy in Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Principalinvestigator

Research Network

Collaboration Network

29 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02270034Phase 1StudyChair

Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma

Glioblastoma Multiforme (Grade IV) of Cerebellum
Completed
NCT01577784Phase 2PrincipalInvestigator

Pazopanib in Second-line Therapy in Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma
Unknown

All 2 trials loaded